Therapeutic Outcomes of High Dose-Dexamethasone versus Prednisolone + Azathioprine, Rituximab, Eltrombopag, and Romiplostim Strategies in Persistent, Chronic, Refractory, and Relapsed Immune Thrombocytopenia Patients.
Autor: | Hamed, Eman Mostafa1 (AUTHOR) eman.hamed@nub.edu.eg, Ibrahim, Ahmed R. N.2 (AUTHOR) eman.hamed@nub.edu.eg, Meabed, Mohamed Hussein3 (AUTHOR) m1hmeabed2@med.bsu.edu.eg, Khalaf, Ahmed M.4 (AUTHOR) dr.ahmed201176@yahoo.com, El Demerdash, Doaa Mohamed5 (AUTHOR) dr_eldemerdash@kasralainy.edu.eg, Elgendy, Marwa O.1,6 (AUTHOR), Saeed, Haitham7 (AUTHOR) haitham.sd1@gmail.com, Salem, Heba F.8,9 (AUTHOR) heba.salem@nub.edu.eg, Rabea, Hoda7 (AUTHOR) hoda.ahmed@pharm.bsu.edu.eg |
---|---|
Zdroj: | Pharmaceuticals (14248247). Sep2023, Vol. 16 Issue 9, p1215. 18p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |